CommonGround 2025 Framework Extends Premium Savings and Advances Healthcare Bills

A bipartisan coalition of 35 U.S. House members, spearheaded by Reps. Josh Gottheimer and Jen Kiggans, unveiled the CommonGround 2025 healthcare framework aimed at extending premium savings for American families. This framework proposes a two-year extension of health insurance premium savings, including one year of enhanced Premium Tax Credits with certain targeted adjustments. The legislation is scheduled for a vote in both the House and Senate by December 18, 2025. The initiative reflects ongoing efforts to sustain affordability and access within the health insurance marketplace amid evolving policy landscapes. In addition to the CommonGround framework, Rep. Jen Kiggans has introduced several bipartisan bills addressing healthcare challenges for specific populations. The Increasing Medication Access for Seniors Act of 2025 is designed to help Medicare beneficiaries manage high medication costs by allowing interest-free monthly payments. This bill aims to improve medication affordability and enhance senior care within Medicare provisions. Rep. Kiggans also introduced the Rx ACCESS Act, focusing on lowering prescription drug costs and improving healthcare access for military families, emphasizing cost equity and supply stability. These legislative efforts underscore a targeted approach to address the unique healthcare needs of veterans and their families through federal policy. Further expanding her legislative portfolio, Kiggans introduced the AI for America Act, which seeks to establish a national AI strategy to reinforce U.S. leadership in artificial intelligence. The act calls for modernization of federal research infrastructure and removal of outdated regulations to foster AI development, impacting future healthcare technology applications and regulatory frameworks. Collectively, these initiatives illustrate a multi-pronged strategy to advance healthcare affordability, access, and innovation through bipartisan cooperation. The focus on premium tax credits, medication affordability, and technological modernization aligns with broader industry and regulatory trends, positioning these proposals as significant components in shaping future U.S. healthcare policy and compliance environments.